Commerce Bank Makes New $748,000 Investment in Ralliant Corporation $RAL

Commerce Bank purchased a new stake in shares of Ralliant Corporation (NYSE:RAL) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 10,163 shares of the company’s stock, valued at approximately $748,000.

A number of other hedge funds have also recently made changes to their positions in the business. BlackRock Inc. bought a new position in shares of Ralliant during the 2nd quarter valued at $1,039,481,000. Dodge & Cox lifted its stake in Ralliant by 13.3% in the fourth quarter. Dodge & Cox now owns 12,214,679 shares of the company’s stock worth $621,849,000 after purchasing an additional 1,434,376 shares during the last quarter. Viking Global Investors LP purchased a new stake in Ralliant during the second quarter valued at about $257,200,000. Millennium Management LLC boosted its position in Ralliant by 172.4% during the fourth quarter. Millennium Management LLC now owns 4,973,001 shares of the company’s stock valued at $253,175,000 after buying an additional 3,147,660 shares during the period. Finally, State Street Corp bought a new position in shares of Ralliant during the second quarter valued at about $213,096,000.

Ralliant Stock Up 4.1%

Shares of NYSE RAL opened at $64.20 on Thursday. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.75. Ralliant Corporation has a 12 month low of $37.27 and a 12 month high of $75.41. The firm has a market capitalization of $7.10 billion, a PE ratio of -5.92, a price-to-earnings-growth ratio of 2.29 and a beta of 1.60. The firm has a fifty day simple moving average of $68.63 and a two-hundred day simple moving average of $56.22.

Ralliant (NYSE:RAL) last announced its earnings results on Thursday, July 30th. The company reported $0.68 earnings per share for the quarter, beating analysts’ consensus estimates of $0.63 by $0.05. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. The firm had revenue of $567.80 million for the quarter. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. Equities analysts expect that Ralliant Corporation will post 2.87 earnings per share for the current year.

Ralliant Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be issued a $0.05 dividend. The ex-dividend date is Tuesday, September 8th. This represents a $0.20 annualized dividend and a yield of 0.3%. Ralliant’s dividend payout ratio (DPR) is -1.84%.

Wall Street Analysts Forecast Growth

RAL has been the topic of several analyst reports. Weiss Ratings reiterated a “sell (d)” rating on shares of Ralliant in a report on Friday, July 31st. Morgan Stanley increased their target price on Ralliant from $68.00 to $85.00 and gave the company an “overweight” rating in a report on Tuesday, June 23rd. Citigroup lifted their price target on Ralliant from $81.00 to $82.00 and gave the stock a “buy” rating in a research note on Friday, July 31st. BMO Capital Markets initiated coverage on Ralliant in a research report on Monday, July 20th. They issued a “market perform” rating and a $78.00 price objective for the company. Finally, Barclays boosted their price objective on Ralliant from $52.00 to $67.00 and gave the company an “overweight” rating in a research report on Wednesday, May 13th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Ralliant currently has an average rating of “Moderate Buy” and a consensus target price of $75.70.

Insider Activity at Ralliant

In other Ralliant news, CEO Tamara S. Newcombe sold 12,936 shares of Ralliant stock in a transaction that occurred on Friday, August 14th. The stock was sold at an average price of $71.79, for a total transaction of $928,675.44. Following the sale, the chief executive officer directly owned 251,967 shares of the company’s stock, valued at approximately $18,088,710.93. The trade was a 4.88% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Karen M. Bick sold 6,062 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $72.00, for a total value of $436,464.00. Following the transaction, the senior vice president owned 31,668 shares in the company, valued at $2,280,096. This trade represents a 16.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.42% of the company’s stock.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.